Diabetes patients on dulaglutide (Trulicity) had better glycemic control and more weight loss if they switched to tirzepatide (Mounjaro) rather than increasing the dose of the earlier-generation ...

Find out how to take Dulaglutide(drug) and its dose. Describes the best time to take the drug and precautions if any that should be followed.

MALVERN, PA — Annovis Bio Inc. (NYSE: ANVS) announced new preclinical data showing the positive combined effects of its lead compound, buntanetap, with the GLP-1 agonist dulaglutide (Trulicity ...

Women who quit smoking and were treated with the GLP-1 receptor agonist dulaglutide were less likely to experience substantial weight gain compared with those who received placebo, according to ...

The study results demonstrated the superiority of mazdutide to dulaglutide in both glycemic control and body weight reduction in Chinese participants with T2D.

OBJECTIVE To compare the efficacy and safety of dulaglutide, a once-weekly GLP-1 receptor agonist, with placebo and exenatide in type 2 diabetic patients.

Glomerular hyperfiltration and proteinuria were reduced among youth with type 2 diabetes who received dulaglutide compared with placebo.

For patients with type 2 diabetes, treatment satisfaction is improved with once-weekly dulaglutide, according to a study published in Diabetes, Obesity and Metabolism.

The current study highlighted the antidepressant effects of dulaglutide using the CMS depression model. Notably, the potential metabolisms that underlie the antidepressant effect of dulaglutide ...

Compared with a combination of insulin glargine, metformin and glimepiride, once-weekly dulaglutide demonstrated superiority and noninferiority as a type 2 diabetes therapy with two different ...

Dulaglutide (Trulicity) effectively boosted blood glucose control in youth with type 2 diabetes, the AWARD-PEDS trial found.

In a rare head-to-head trial of two GLP-1 receptor agonists, once-weekly dulaglutide was similar to once-daily liraglutide in efficacy and tolerability.